Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Serum terminal complement component levels in hypocomplementemic glomerulonephritides.

C W Clardy1, J Forristal, C F Strife

  • 1Children's Hospital Research Foundation, Cincinnati, Ohio 45229.

Clinical Immunology and Immunopathology
|March 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Blood amino nitrogen levels; changes in blood amino nitrogen levels following ingestion of proteins and of a protein hydrolysate in infants with normal and with deficient pancreatic function.

American journal of diseases of children (1911)·2010
Same author

Pharmacokinetics of oral valganciclovir solution and intravenous ganciclovir in pediatric renal and liver transplant recipients.

Transplant infectious disease : an official journal of the Transplantation Society·2009
Same author

Acquired renal cysts after pediatric liver transplantation: association with cyclosporine and renal dysfunction.

Pediatric transplantation·2008
Same author

Disease outcomes and ovarian function of childhood-onset systemic lupus erythematosus.

Lupus·2006
Same author

Nuclear emissions during self-nucleated acoustic cavitation.

Physical review letters·2006
Same author

Additional evidence of nuclear emissions during acoustic cavitation.

Physical review. E, Statistical, nonlinear, and soft matter physics·2004
Same journal

Mechanisms of virus replication, persistence, and regulation of immune responses.

Clinical immunology and immunopathology·2020
Same journal

Cumulative subject index for volumes 86-89

Clinical immunology and immunopathology·1998
Same journal

D-penicillamine-induced pancreatic islet autoantibody production is independent of the immunogenetic background: a lesson from patients with Wilson's disease.

Clinical immunology and immunopathology·1998
Same journal

Characterization of gastric Na+/I- symporter of the rat.

Clinical immunology and immunopathology·1998
Same journal

CD8(+), radiosensitive T cells of parental origin, oppose cells capable of down-regulating cytotoxicity in murine acute lethal graft-versus-host disease.

Clinical immunology and immunopathology·1998
Same journal

Specific activity of alpha1proteinase inhibitor and alpha2macroglobulin in human serum: application to insulin-dependent diabetes mellitus.

Clinical immunology and immunopathology·1998
See all related articles

Complement component levels differ in glomerulonephritis types. Membranoproliferative glomerulonephritis type III (MPGN III) shows greater late terminal complement component activation compared to other forms like acute poststreptococcal glomerulonephritis (AGN).

Area of Science:

  • Nephrology
  • Immunology
  • Complement System

Background:

  • The complement system, particularly its terminal components (C3-C9), plays a role in various kidney diseases.
  • Understanding complement activation patterns in different glomerulonephritis subtypes is crucial for diagnosis and understanding pathogenesis.

Purpose of the Study:

  • To investigate and compare the levels of serum complement components C3 through C9 in patients with different types of glomerulonephritis.
  • To elucidate the specific patterns of complement activation in acute poststreptococcal glomerulonephritis (AGN), membranoproliferative glomerulonephritis type I (MPGN I), MPGN II, and MPGN III.

Main Methods:

  • Serum samples from patients diagnosed with AGN, MPGN I, MPGN II, and MPGN III were analyzed.
  • Quantitative measurements of complement components C3, C5, C6, C7, C8, and C9 were performed.

Related Experiment Videos

Main Results:

  • Depressed C5 levels correlated with depressed C3 levels in all glomerulonephritis types except MPGN II, where levels were normal.
  • MPGN III exhibited markedly depressed levels of C7-C9, strongly correlating with low C3 and C5, indicating significant late terminal complement activation.
  • AGN and MPGN I showed less frequent depression of terminal components, with severe depression only occurring at extremely low C3 and C5 levels.

Conclusions:

  • Late terminal complement components are activated to a greater extent in MPGN III compared to AGN, MPGN I, and MPGN II.
  • Despite similar C5 activation extents in MPGN III and AGN, the degree of late terminal component activation differs significantly.
  • These findings highlight distinct complement activation pathways in different glomerulonephritis subtypes, with MPGN III showing a unique pattern of terminal pathway engagement.